← Back to headlines
UBS and Jefferies Downgrade Medtronic (MDT) Amid Diabetes Unit Restructuring
UBS and Jefferies have lowered their outlooks on Medtronic (MDT) following changes within the company's diabetes unit.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines Grapples with Plastic Waste Leakage Despite Existing Laws
just now
Visayas Sugar Farms Face Insect Infestation, Prompting Emergency Meeting
just now
Philippines: Loboc River P3.5-B Protection Project Under Scrutiny
just now